These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8890477)

  • 1. T cell hyperreactivity to IL-6 in chronic nonviremic HBV carriers despite normal IL-6 receptor or gp130 expression.
    Baroja ML; Sirit FL; Rivera H; Garzaro J; Bianco NE; Machado IV
    Viral Immunol; 1996; 9(3):187-94. PubMed ID: 8890477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-CD3-activated T cells from chronic nonviremic HBV carriers are hyperreactive to monocytic accessory signals.
    Baroja ML; Sirit FL; Caldera DJ; Toro FI; Zabaleta ME; Colmenares CJ; Bianco NE; Machado IV
    Clin Immunol Immunopathol; 1993 Nov; 69(2):180-8. PubMed ID: 8403555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human T cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal.
    Ceuppens JL; Baroja ML; Lorre K; Van Damme J; Billiau A
    J Immunol; 1988 Dec; 141(11):3868-74. PubMed ID: 3263438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on HBV antigens and IL-12 affecting T cell-mediated immunity in HBsAg carriers].
    Lin BL; Xie DY; Xie JQ; Zhang XH; Mei YY; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2011 Mar; 19(3):186-90. PubMed ID: 21586236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of hepatitis B surface antigen (HBsAg) induced interleukin-2 secretion in chronic asymptomatic carriers of HBsAg.
    Sylvan SP; Hekkström UB
    Clin Exp Immunol; 1989 Nov; 78(2):207-13. PubMed ID: 12412750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
    Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
    Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal T-cell activation in chronic hepatitis B viral infection: a consequence of monocyte dysfunction?
    Nouri-Aria KT; Magrin S; Alexander GJ; Anderson MG; Williams R; Eddleston AL
    Immunology; 1988 Aug; 64(4):733-8. PubMed ID: 2971612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gp130 and the interleukin-6 family of cytokines.
    Taga T; Kishimoto T
    Annu Rev Immunol; 1997; 15():797-819. PubMed ID: 9143707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis B virus carriers have low lymphoproliferative responses to HBsAg and reduced interleukin-2 synthesis.
    Nagaraju K; Naik SR; Naik S
    Indian J Gastroenterol; 1998; 17(3):83-6. PubMed ID: 9695386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-10 production is enhanced in human T cells by IL-12 and IL-6 and in monocytes by tumor necrosis factor-alpha.
    Daftarian PM; Kumar A; Kryworuchko M; Diaz-Mitoma F
    J Immunol; 1996 Jul; 157(1):12-20. PubMed ID: 8683105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies.
    Wijdenes J; Heinrich PC; Müller-Newen G; Roche C; Gu ZJ; Clément C; Klein B
    Eur J Immunol; 1995 Dec; 25(12):3474-81. PubMed ID: 8566040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 promotes HBV-specific central memory CD8+ T cell responses by PBMCs from chronic hepatitis B virus carriers.
    Xiong SQ; Lin BL; Gao X; Tang H; Wu CY
    Int Immunopharmacol; 2007 May; 7(5):578-87. PubMed ID: 17386405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific inhibition of IL-6 signalling with monoclonal antibodies against the gp130 receptor.
    Liautard J; Sun RX; Cotte N; Gaillard JP; Mani JC; Klein B; Brochier J
    Cytokine; 1997 Apr; 9(4):233-41. PubMed ID: 9112331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T4 cell activation by immobilized phytohemagglutinin: differential capacity to induce IL-2 responsiveness and IL-2 production.
    Vine JB; Geppert TD; Lipsky PE
    J Immunol; 1988 Oct; 141(8):2593-600. PubMed ID: 2844904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of interleukin-6 (IL-6), IL-6 receptor, and gp130-kilodalton glycoprotein in the rat decidua and a decidual cell line: regulation by 17beta-estradiol and prolactin.
    Deb S; Tessier C; Prigent-Tessier A; Barkai U; Ferguson-Gottschall S; Srivastava RK; Faliszek J; Gibori G
    Endocrinology; 1999 Oct; 140(10):4442-50. PubMed ID: 10499497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers.
    Zou JP; Morford LA; Chougnet C; Dix AR; Brooks AG; Torres N; Shuman JD; Coligan JE; Brooks WH; Roszman TL; Shearer GM
    J Immunol; 1999 Apr; 162(8):4882-92. PubMed ID: 10202033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell surface glycoproteins expressed on activated human T cells induce production of interleukin-1 beta by monocytic cells: a possible role of CD69.
    Isler P; Vey E; Zhang JH; Dayer JM
    Eur Cytokine Netw; 1993; 4(1):15-23. PubMed ID: 8490101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
    Westendorf JJ; Jelinek DF
    J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of human T cell response to mitogens: IL 2 induces IL 2 receptor expression and proliferation but not IL 2 synthesis in PHA-stimulated T cells.
    Katzen D; Chu E; Terhost C; Leung DY; Gesner M; Miller RA; Geha RS
    J Immunol; 1985 Sep; 135(3):1840-5. PubMed ID: 3926887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels.
    Szabo G; Mandrekar P; Dolganiuc A; Catalano D; Kodys K
    Alcohol Clin Exp Res; 2001 Dec; 25(12):1766-72. PubMed ID: 11781510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.